Clinuvel Pharmaceuticals
CUV.AX
#8532
Rank
C$0.39 B
Marketcap
C$7.91
Share price
0.13%
Change (1 day)
-28.69%
Change (1 year)

Earnings for Clinuvel Pharmaceuticals (CUV.AX)

Earnings in 2026: C$46.99 Million

According to Clinuvel Pharmaceuticals's latest financial reports the company's current earnings are C$64.99 Million. In 2026 the company made an earning of C$46.99 Million a decrease over its 2025 earnings that were of C$48.37 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Clinuvel Pharmaceuticals from 2000 to 2026

Annual earnings

Year Earnings Change
2026C$46.99 M-2.84%
2025C$48.37 M0.26%
2024C$48.24 M11.35%
2023C$43.32 M28.31%
2022C$33.77 M22.8%
2021C$27.5 M112.63%
2020C$12.93 M-28.73%
2019C$18.14 M32.79%
2018C$13.66 M75.41%
2017C$7.79 M-332.52%
2016-C$3.36 Million-70.68%
2015-C$11.44 Million53.78%
2014-C$7.44 Million-16.1%
2013-C$8.86 Million-37.92%
2012-C$14.28 Million-18.19%
2011-C$17.45 Million25.31%
2010-C$13.93 Million-21.53%
2009-C$17.75 Million-11.27%
2008-C$20 Million80.4%
2007-C$11.09 Million-2.46%
2006-C$11.37 Million-5.35%
2005-C$12.01 Million60.55%
2004-C$7.48 Million97.37%
2003-C$3.79 Million50.62%
2002-C$2.52 Million121.22%
2001-C$1.14 Million254.48%
2000-C$0.33 Million